Skip to main content
. 2017 May;14(2):132–140. doi: 10.2174/1567202614666170306105315

Fig. (3).

Fig. (3)

The tanshinone IIA treatment inhibits OGD/R-increased intracellular reactive oxygen species (ROS). Tanshinone IIA treatment significantly suppresses the OGD6/R6-increased the intracellular ROS that were detected with a CM-H2DCFDA probe. Representative photographs of fluorescence (A). The fluorescence is determined at 485/528 nm (B). Scale bar represents 50 µm. **p<0.01.